DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Amrutanjan Health Care Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·7 Oct 2026, 4:55 am

Amrutajan Health

Amrutanjan Health Care Limited has informed stock exchanges that it has received a certificate under SEBI's Depositories and Participants Regulations, 2018. This document confirms that the company's shares are eligible for electronic settlement and dematerialization, ensuring compliance with regulatory standards for trading.

For investors, this is a routine administrative update that validates the company's adherence to market infrastructure rules. It reinforces the transparency and regulatory compliance of the stock, which is essential for maintaining investor confidence in the trading process.

Investors should note that this news does not reflect any operational changes or financial performance. It is primarily a procedural confirmation. Market participants should continue to monitor the company's official disclosures for any material updates regarding its business operations.